Loading...
A Systematic Review of Network Meta-Analyses and Real-World Evidence Comparing Apixaban and Rivaroxaban in Nonvalvular Atrial Fibrillation
There is no direct evidence comparing the 2 most commonly prescribed direct oral anticoagulants, apixaban and rivaroxaban, used for stroke prevention in nonvalvular atrial fibrillation (NVAF). A number of network meta-analyses (NMAs) of randomized control trials and real-world evidence (RWE) studies...
Na minha lista:
| Udgivet i: | Clin Appl Thromb Hemost |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7098208/ https://ncbi.nlm.nih.gov/pubmed/31918558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029619898764 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|